Early Stage Venture BioShin Raises Series A of $60000000

September 27, 2020

About BioShin

BioShin is a clinical-stage biopharmaceutical company focused on developing medicines for the Asia-Pacific region.

Website: Learn more on BioShin’s website

Crunchbase: Follow on Crunchbase

[adace-ad id=”4426″]

Series A – BioShin

Amount Raised60000000 USD
Announced Date2020-09-28
Equity Only FundingYes
Organization LocationShanghai, Shanghai, China, Asia
Funding StatusEarly Stage Venture
Number of Funding Rounds1
Lead InvestorsOrbiMed
Number of Investors5
Number of Partner Investors1